{"id":20250,"date":"2025-09-22T14:07:45","date_gmt":"2025-09-22T11:07:45","guid":{"rendered":"https:\/\/dd.deweb-servers.com\/?p=20250"},"modified":"2025-09-24T01:06:56","modified_gmt":"2025-09-23T22:06:56","slug":"%ce%b6%cf%89%ce%b9%ce%b4%ce%ac%ce%ba%ce%b7%cf%82-%ce%b9%ce%b5%cf%81%cf%8e%ce%bd%cf%85%ce%bc%ce%bf%cf%82","status":"publish","type":"post","link":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/%ce%b6%cf%89%ce%b9%ce%b4%ce%ac%ce%ba%ce%b7%cf%82-%ce%b9%ce%b5%cf%81%cf%8e%ce%bd%cf%85%ce%bc%ce%bf%cf%82\/","title":{"rendered":"\u0396\u03c9\u03b9\u03b4\u03ac\u03ba\u03b7\u03c2 \u0399\u03b5\u03c1\u03ce\u03bd\u03c5\u03bc\u03bf\u03c2"},"content":{"rendered":"
\n
\n
\n

\u0392\u03b9\u03bf\u03b3\u03c1\u03b1\u03c6\u03b9\u03ba\u03cc<\/h3>\n<\/div>\n<\/div>\n<\/div>\n
\n
\n
\n

Education\u00a0<\/span><\/b><\/span><\/p>\n

1999-2004: University of California Los Angeles, U.S.A., Ph.D. in Biochemistry\u00a0<\/span><\/b><\/span><\/p>\n

1992-1997: University of Liege, Belgium, Licence in Biochemistry\u00a0<\/span><\/b><\/span><\/p>\n

Professional Experience\u00a0<\/span><\/b><\/span><\/p>\n

2022-current:\u00a0<\/b>National and Kapodistrian University of Athens, Assistant Professor of Biochemistry, Biology Department\u00a0<\/span><\/span><\/p>\n

Biomedical Research Foundation, Academy of Athens, Associated Faculty\u00a0<\/span><\/span><\/p>\n

2008-current<\/b>: Biomedical Research Foundation, Academy of Athens. Senior Research Scientist and Associated Faculty, Proteomics Laboratory\u00a0<\/span><\/span><\/p>\n

2007-2008:\u00a0<\/b>Biotypos Clinical Laboratory. Athens, Greece. Clinical Biochemist. Responsible for Biochemical and Antibody-based assays, including cancer biomarkers\u00a0<\/span><\/span><\/p>\n

Research experience\u00a0<\/span><\/b><\/span><\/p>\n

2022-current: NKUA\u00a0<\/b>and\u00a02012-current: BRFAA.\u00a0<\/span><\/b><\/span><\/p>\n

Proteomics of tissues and biological fluids. Systems Biology analysis of proteomics, transcriptomics, genomics, and metabolomics data in the context of Multiple Myeloma, Colorectal Cancer, Chronic Kidney Disease (CKD), cardiovascular disorders, bladder cancer, prostate cancer, and multiple myeloma, aiming to discover novel biomarkers and therapeutic targets. Bioinformatics analysis of -omics datasets for defining the biochemical processes in healthy tissues and their deregulation in disease.\u00a0<\/span><\/span><\/p>\n

Supervision of 8 PhD students and 7 postdoctoral fellows.\u00a0<\/span><\/span><\/p>\n

2012- 2016:\u00a0<\/b>BRFAA. Cervical cancer biomarker discovery by proteomic approaches. Research adviser for 2 PhD students\u00a0<\/span><\/span><\/p>\n

2008-2011:\u00a0<\/b>BRFAA. Characterization of the urinary proteome. Discovery and validation of candidate bladder cancer biomarkers by mass spectrometry, ELISA, and WB.\u00a0<\/span><\/span><\/p>\n

2000-2004:\u00a0<\/b>UCLA. Kinetic and biophysical studies of the enzymes Phenylalanine Hydroxylase from\u00a0Chromobacterium violaceum\u00a0<\/i>and 1-Aminocyclopropane-1-Carboxylate Deaminase from\u00a0Pseudomonas putida\u00a0<\/span><\/i><\/span><\/p>\n

1996-1997:\u00a0<\/b>University of Liege and Foundation of Research and Technology, Crete, Greece. Cloning, purification and characterization of a psychrophilic chitobiase from the Antarctic bacterium\u00a0Arthrobacter sp. TAD20<\/i>.\u00a0<\/span><\/span><\/p>\n

Teaching experience\u00a0<\/span><\/b><\/span><\/p>\n

2022-curent:\u00a0<\/b>Lectures and laboratories for the undergraduate classes of the Biology Department, NKUA: Biochemistry, Molecular Biology, Advanced Topics of Biochemistry\u00a0<\/span><\/span><\/p>\n

2015-current:\u00a0<\/b>Organizer and instructor of short courses and workshops relative to \u201cproteomics\u201d, \u201cMRM\u201d and \u201cpreparing future faculty for teaching\u201d offered in the context of EU funded Innovative Training Network programs for PhD students and post-doctoral researchers\u00a0<\/span><\/span><\/p>\n

2010-current:\u00a0<\/b>Teaching proteomics and genomics classes for Masters Courses offered by the National and Kapodistrian University of Athens, the Aristotle University of Thessaloniki, the Democritus University of Thrace and the Agricultural University of Athens with particular focus on clinical applications<\/span><\/p>\n

2003-2004: Member of the Collegium of University Teaching Fellows at UCLA\u00a0<\/span><\/b><\/span><\/p>\n

Designed and taught a class entitled \u201cApplications of enzymes\u201d offered in the Spring of 2004\u00a0<\/span><\/span><\/p>\n

2002-2004:\u00a0<\/b>Teaching Assistant Consultant responsible for the training of the new TAs at the UCLA department of Chemistry and Biochemistry.\u00a0<\/span><\/span><\/p>\n

Reorganized the TA training program of the department. Evaluated 46 TAs and helped them improve their teaching by giving them detailed reports and constructive criticism\u00a0<\/span><\/span><\/p>\n

1999-2003:\u00a0<\/b>Teaching Assistant for lecture and laboratory courses at UCLA. Led discussions for the classes,\u00a0Biochemistry: Structure, Enzymes, and Metabolism\u00a0<\/i>and\u00a0Environmental Chemistry<\/i>. Directed laboratory sections for the class\u00a0Biochemical Methods I.\u00a0<\/span><\/i><\/span><\/p>\n

Excellence in Teaching has been recognized by Departmental (2001) and University (2004) awards at UCLA and invited lectures as an expert on preparing future faculty for teaching careers in the US and Europe (example: 2018 FEBS Educational Workshop on Molecular Life Sciences).\u00a0<\/span><\/i><\/span><\/p>\n

Book\u00a0<\/span><\/b><\/span><\/p>\n

Editor of the book \u201cIntegration of omics approaches and systems biology for clinical applications\u201d Wiley 2018\u00a0<\/span><\/span><\/p>\n

Involvement in EU COST (Cooperation in Science and Technology) actions\u00a0<\/span><\/b><\/span><\/p>\n

Managing Committee member for PERMEDIK (Personalized Medicine in Kidney Disease).\u00a0<\/span><\/span><\/p>\n

Participating in the CLIMARK (good biomarker practice\u2019 to increase the number of clinically validated biomarkers, 2017-2021) COST action as the coordinator of education activities and short-term scientific visits (STSM).\u00a0<\/span><\/span><\/p>\n

Responsible for managing a budget of 10,000 in the first year of the program and 35,000 for the second year. Coordinated the STSM of 36 researchers from 01\/05\/2017 to 30\/09\/2021.\u00a0<\/span><\/span><\/p>\n

Organizer of the COST CLINIMARK training school:\u00a0<\/b>Approaches for Biomarker Discovery and Validation, Spetses 23-27\/09\/19 involving 24 trainers and 34 trainees (budget 44,000 \u20ac)\u00a0<\/span><\/span><\/p>\n

https:\/\/clinimark.eu\/component\/icagenda\/9-cost-clinimark-training-school.html?Itemid=102\u00a0<\/span><\/span><\/p>\n\n\n\n\n\n\n
\n

Current grant support\u00a0<\/b>Project\u00a0<\/span><\/i><\/span><\/p>\n<\/td>\n

\n

Funding source\u00a0<\/span><\/i><\/span><\/p>\n<\/td>\n

\n

Amount (\u20ac)\u00a0<\/span><\/i><\/span><\/p>\n<\/td>\n

\n

Period\u00a0<\/span><\/i><\/span><\/p>\n<\/td>\n

\n

Role\u00a0<\/span><\/i><\/span><\/p>\n<\/td>\n

\n

Research focus\u00a0<\/span><\/i><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

EPAND-EV\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

EU MSCA\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

78,000\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

01\/01\/2025 31\/12\/2028\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

PI\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

Use of Extracellular Vesicles for biomedical applications\u00a0<\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

STEPUPIORS\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

EU Twinning\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

250,000\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

01\/10\/2022\u00a0<\/span><\/span><\/p>\n

30\/09\/2025\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

PI\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

Research and management expertise transfer to IORS\u00a0<\/span><\/span><\/p>\n<\/td>\n<\/tr>\n

\n

ELMUMY\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

EU Horizon\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

467,895\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

01\/01\/2023\u00a0<\/span><\/span><\/p>\n

31\/12\/2026\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

PI\u00a0<\/span><\/span><\/p>\n<\/td>\n

\n

Creation of a molecular model for multiple myeloma\u00a0<\/span><\/span><\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Publications\u00a0<\/span><\/b><\/span><\/p>\n

95 Publications in Peer Review Journals. H-index 26, 1989 citations (Scopus, 2\/2025)\u00a0<\/span><\/b><\/span><\/p>\n

https:\/\/www.scopus.com\/authid\/detail.uri?authorId=6506081730\u00a0<\/span><\/b><\/span><\/p>\n

More than 100 oral\/poster presentations in national and international scientific meetings. Invited lectures on proteomics and the scholarship of teaching at scientific meetings and workshops.\u00a0<\/span><\/b><\/span><\/p>\n

EU Patent (Designated as inventor)\u00a0<\/span><\/b><\/span><\/p>\n

 <\/p>\n

Date filed 23\/12\/2016 Title: Bladder cancer Biomarker Proteins Application No. 15202453.5-1405<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Assistant Professor of Biochemistry<\/p>\n","protected":false},"author":1,"featured_media":20189,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[13],"tags":[],"class_list":["post-20250","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-personnel"],"acf":[],"_links":{"self":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts\/20250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/comments?post=20250"}],"version-history":[{"count":1,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts\/20250\/revisions"}],"predecessor-version":[{"id":20312,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/posts\/20250\/revisions\/20312"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/media\/20189"}],"wp:attachment":[{"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/media?parent=20250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/categories?post=20250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugdevelop-msc.med.uoa.gr\/en\/wp-json\/wp\/v2\/tags?post=20250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}